Rhumbline Advisers Neogenomics Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Neogenomics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 389,003 shares of NEO stock, worth $3.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
389,003
Previous 379,905 2.39%
Holding current value
$3.74 Million
Previous $5.6 Million 14.4%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
BUY
$13.0 - $18.43 $118,274 - $167,676
9,098 Added 2.39%
389,003 $6.41 Million
Q3 2024

Nov 12, 2024
SELL
$13.4 - $17.73 $32,575 - $43,101
-2,431 Reduced 0.64%
379,905 $5.6 Million
Q2 2024

Aug 01, 2024
SELL
$13.01 - $15.77 $42,893 - $51,993
-3,297 Reduced 0.85%
382,336 $5.3 Million
Q1 2024

May 09, 2024
BUY
$14.06 - $16.79 $9,757 - $11,652
694 Added 0.18%
385,633 $6.06 Million
Q4 2023

Feb 08, 2024
SELL
$11.67 - $20.73 $296,954 - $527,495
-25,446 Reduced 6.2%
384,939 $6.23 Million
Q3 2023

Nov 09, 2023
BUY
$12.15 - $17.85 $9,100 - $13,369
749 Added 0.18%
410,385 $5.05 Million
Q2 2023

Aug 08, 2023
SELL
$14.1 - $19.83 $122,980 - $172,957
-8,722 Reduced 2.08%
409,636 $6.58 Million
Q1 2023

May 11, 2023
BUY
$9.09 - $19.45 $114,370 - $244,719
12,582 Added 3.1%
418,358 $7.28 Million
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $191,100 - $357,609
29,628 Added 7.88%
405,776 $3.75 Million
Q3 2022

Nov 10, 2022
BUY
$7.86 - $12.91 $132,142 - $217,042
16,812 Added 4.68%
376,148 $3.24 Million
Q2 2022

Aug 11, 2022
BUY
$7.06 - $13.97 $404,361 - $800,131
57,275 Added 18.96%
359,336 $2.93 Million
Q1 2022

May 12, 2022
BUY
$12.15 - $35.28 $237,994 - $691,064
19,588 Added 6.93%
302,061 $3.67 Million
Q4 2021

Feb 10, 2022
BUY
$30.49 - $48.49 $277,550 - $441,404
9,103 Added 3.33%
282,473 $9.64 Million
Q3 2021

Nov 12, 2021
SELL
$41.66 - $52.52 $1.65 Million - $2.08 Million
-39,696 Reduced 12.68%
273,370 $13.2 Million
Q2 2021

Aug 05, 2021
SELL
$36.62 - $51.69 $38,670 - $54,584
-1,056 Reduced 0.34%
313,066 $14.1 Million
Q1 2021

May 06, 2021
BUY
$41.56 - $59.88 $547,719 - $789,158
13,179 Added 4.38%
314,122 $15.2 Million
Q4 2020

Feb 10, 2021
BUY
$36.08 - $56.47 $347,450 - $543,806
9,630 Added 3.31%
300,943 $16.2 Million
Q3 2020

Nov 12, 2020
SELL
$33.26 - $40.48 $1.1 Million - $1.34 Million
-33,177 Reduced 10.22%
291,313 $10.7 Million
Q2 2020

Aug 13, 2020
BUY
$24.21 - $31.02 $84,105 - $107,763
3,474 Added 1.08%
324,490 $10.1 Million
Q1 2020

May 06, 2020
BUY
$20.5 - $34.53 $102,561 - $172,753
5,003 Added 1.58%
321,016 $8.86 Million
Q4 2019

Feb 05, 2020
BUY
$18.96 - $29.84 $376,564 - $592,652
19,861 Added 6.71%
316,013 $9.24 Million
Q3 2019

Oct 23, 2019
BUY
$19.12 - $26.24 $295,174 - $405,093
15,438 Added 5.5%
296,152 $5.66 Million
Q2 2019

Aug 14, 2019
BUY
$19.57 - $24.1 $608,940 - $749,895
31,116 Added 12.47%
280,714 $6.16 Million
Q1 2019

May 01, 2019
BUY
$12.14 - $20.46 $1.99 Million - $3.35 Million
163,698 Added 190.57%
249,598 $5.11 Million
Q4 2018

Jan 31, 2019
BUY
$11.24 - $18.5 $355,622 - $585,321
31,639 Added 58.31%
85,900 $1.08 Million
Q3 2018

Nov 07, 2018
SELL
$12.5 - $15.38 $11,600 - $14,272
-928 Reduced 1.68%
54,261 $833,000
Q2 2018

Aug 06, 2018
BUY
$7.99 - $14.05 $25,120 - $44,173
3,144 Added 6.04%
55,189 $724,000
Q1 2018

May 02, 2018
SELL
$7.23 - $8.76 $6,723 - $8,146
-930 Reduced 1.76%
52,045 $425,000
Q4 2017

Feb 09, 2018
SELL
$8.02 - $11.18 $75,388 - $105,092
-9,400 Reduced 15.07%
52,975 $469,000
Q3 2017

Nov 06, 2017
BUY
$9.11 - $11.26 $568,236 - $702,342
62,375
62,375 $694,000

Others Institutions Holding NEO

# of Institutions
281
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.21B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email